Activation of p73 silent allele in lung cancer

Cancer Research

Volumn 58, Issue 11, 1998, Pages 2347-2349

  Mai, Ming ^a   Yokomizo, Akira ^a   Qian, Chiping ^a   Yang, Ping ^a   Tindall, Donald J ^a   Smith, David I ^a   Liu, Wanguo ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

AMINO ACID SEQUENCE; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; DNA POLYMORPHISM; GENE ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; LUNG CANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SILENT GENE;

ALLELES; APOPTOSIS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0032100611     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
2. Levine, A. J., Momand, J., and Finlay, C. A. The p53 tumour suppressor gene. Nature (Lond.), 351: 453-456, 1991.
3. Haffner, R., and Oren, M. p53: biochemical properties and biological effects of p53. Curr. Opin. Genet. Dev., 5: 84-90, 1995.
4. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J-C., Valent, A., Minty, A., Chalon, P., Lelias, J-M., Dumount, X., Ferrara, P., Mckeon, F., and Caput, D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 90: 809-819, 1997.
5. Oren, M. Lonely no more: p53 finds its kin in a tumor suppressor haven. Cell, 90: 829-832, 1997.
6. Dickman, S. First p53 relative may be a new tumor suppressor. Science (Washington DC), 277: 1605-1606, 1997.
7. Clurman, B., and Groudine, M. Killer in search of a motive? Nature (Lond.), 389: 122-123, 1997.
8. Jost, C. A., Marin, M. C., and Kaelin, W. G. p73 is a human p53-related protein that can induce apoptosis. Nature (Lond.). 389: 191-194, 1997.
9. Pisani, P., Parkin, D. M., and Ferlay, J. Estimates of the worldwide mortality from eighteen major cancers in 1985: implications for prevention and projections of future burden. Int. J. Cancer, 55; 891-903, 1993.
10. Gazzeri, S., Brambilla, E., Caron, de Fromentel, C., Gouyer, V., Moro, D., Perron, P., Berger, F., and Brambilla, C. p53 genetic abnormalities and myc activation in human lung carcinoma. Int. J. Cancer, 58: 24-32, 1994.
11. Suzuki, H., Ueda, R., Takahashi, T., and Takahashi, T. Altered imprinting in lung cancer. Nat. Genet., 6: 332-333, 1995.
12. Denissenko, M. F., Pao, A., Tang, M., and Pfeifer, G. P. Preferential formation of benzo(a)pyrene adducts at lung cancer mutational hotspots in p53. Science (Washington DC), 274: 430-432, 1996.
13. Singer-Sam, J., Chapman, V., LeBon, J. M., and Riggs, A. D. Parental imprinting studied by allele-specific primer extension after PCR: paternal X chromosome-linked genes are transcribed prior to preferential paternal X chromosome inactivation. Proc. Natl. Acad. Sci. USA, 89: 10469-10473, 1992.
14. Gibson, R. A., Buchwald, M., Roberts, R. G., and Mathew, C. G. Characterization of the exon structure of the Fanconi anaemia group C gene by vectorette PCR. Hum. Mol. Genet., 2: 35-38, 1993.
15. Liu, W., James, D., Frederick, L., Alderete, B. E., and Jenkins, R. B. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res., 57: 5254-5257, 1997.
16. 2+ channel gene CACNL1A4 19p. Cell, 87: 1-20, 1996.
17. Ogawa, O., Eccles, M. R., Szeto, J., McNoe, L. A., Yun, K., Maw, M. A., Smith, P. J., and Reeve, A. E., Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumor. Nature (Lond.), 362: 749-751, 1993.
18. Rainier, S., Johnson, L. A., Dobry, C. J., Ping, A. J., Grundy, P. E., and Frinberg, A. P. Relaxation of imprinted genes in human cancer. Nature (Lond.), 362: 747-749, 1993.
19. Rachmilewitz, J., Elkin, M., Looijenga, L. H., Verkerk, A. J., Gonik, B., Lustig, O., Werner, D., de Groot, N., and Hochberg, A. Characterization of the imprinted IPW gene: allelic expression I normal and tumorigenic human tissues. Oncogene, 13: 1687-1692, 1996.
20. Thompson, J. S., Reese, K. J., DeBaun, M. R., Perlman, E. J., and Feinberg, A. P. Reduced expression of the cyclin-dependent kinase inhibitor gene p57KIP2 in Wilms' tumor. Cancer Res., 56: 5723-5727, 1996.
21. Hibi, K., Nakamura, H., Hirai, A., Fujikake, Y., Kasai, Y., Akiyama, S., Ito, K., and Takagi, H. Loss of H19 imprinting in esophageal cancer. Cancer Res., 56: 480-482, 1996.
22. Kondo, M., Suzuki, H., Ueda, R., Osada, H., Takagi, K., Takahashi, T., and Takahashi, T. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene, 10: 1193-1198, 1995.